A press release was published on the UK Government website with details about the approval of Mounjaro. With studies showing "Significant decreases in body weight" this means another option for you to use on your weight loss journey.
Four-dose Mounjaro “KwikPen” approved by MHRA for diabetes and weight management - GOV.UK (www.gov.uk)
"Across all the studies, participants who received tirzepatide showed significant decreases in fasting glucose levels compared to either placebo or an active control (semaglutide, insulin degludec and insulin glargine) for up to 1 year. In one study these effects were sustained for up to 2 years. Significant decreases in body weight were also demonstrated."
Commenti